628 related articles for article (PubMed ID: 18700896)
21. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
22. Molecular screening of partners of cystic fibrosis heterozygotes.
Shrimpton AE; Brock DJ
Genet Couns; 1992; 3(1):13-8. PubMed ID: 1375470
[TBL] [Abstract][Full Text] [Related]
23. Prenatal screening for cystic fibrosis: past, present and future.
Richards CS; Grody WW
Expert Rev Mol Diagn; 2004 Jan; 4(1):49-62. PubMed ID: 14711349
[TBL] [Abstract][Full Text] [Related]
24. Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening.
Faden RR; Tambor ES; Chase GA; Geller G; Hofman KJ; Holtzman NA
Am J Med Genet; 1994 Mar; 50(1):1-11. PubMed ID: 8160745
[TBL] [Abstract][Full Text] [Related]
25. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
[TBL] [Abstract][Full Text] [Related]
26. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation.
Wang X; Kim J; McWilliams R; Cutting GR
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):237-40. PubMed ID: 15781764
[TBL] [Abstract][Full Text] [Related]
27. Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.
Watson EK; Marchant J; Bush A; Williamson B
J Med Genet; 1992 Jul; 29(7):490-1. PubMed ID: 1640429
[TBL] [Abstract][Full Text] [Related]
28. The D1152H cystic fibrosis mutation in prenatal carrier screening, patients and prenatal diagnosis.
Peleg L; Karpati M; Bronstein S; Berkenstadt M; Frydman M; Yonath H; Pras E
J Med Screen; 2011; 18(4):169-72. PubMed ID: 22156145
[TBL] [Abstract][Full Text] [Related]
29. ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.
Obstet Gynecol; 2011 Apr; 117(4):1028-1031. PubMed ID: 21422883
[TBL] [Abstract][Full Text] [Related]
30. Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations.
DeMarchi JM; Beaudet AL; Caskey CT; Richards CS
Arch Pathol Lab Med; 1994 Jan; 118(1):26-32. PubMed ID: 8285831
[TBL] [Abstract][Full Text] [Related]
31. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
[TBL] [Abstract][Full Text] [Related]
32. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
[TBL] [Abstract][Full Text] [Related]
33. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations.
Schrijver I; Oitmaa E; Metspalu A; Gardner P
J Mol Diagn; 2005 Aug; 7(3):375-87. PubMed ID: 16049310
[TBL] [Abstract][Full Text] [Related]
34. Genetic testing and quality control in diagnostic laboratories.
Dequeker E; Cassiman JJ
Nat Genet; 2000 Jul; 25(3):259-60. PubMed ID: 10888869
[TBL] [Abstract][Full Text] [Related]
35. Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines.
Darcy D; Tian L; Taylor J; Schrijver I
Genet Test Mol Biomarkers; 2011; 15(7-8):517-23. PubMed ID: 21453058
[TBL] [Abstract][Full Text] [Related]
36. Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers.
Rowley PT; Loader S; Levenkron JC; Phelps CE
Am J Prev Med; 1993; 9(5):261-6. PubMed ID: 8257614
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'ava-Santucci J; Dusser D
J Cyst Fibros; 2004 Mar; 3(1):15-22. PubMed ID: 15463882
[TBL] [Abstract][Full Text] [Related]
38. Genetic and immunologic aspects of cystic fibrosis.
Hilman BC
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):379-90; quiz 391-4. PubMed ID: 9396969
[TBL] [Abstract][Full Text] [Related]
39. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
[TBL] [Abstract][Full Text] [Related]
40. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
